Vivos Therapeutics (VVOS) Total Non-Current Liabilities (2022 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Total Non-Current Liabilities of $25.0 million for Q1 2026, down 1.58% quarter-over-quarter from $25.4 million in Q4 2025.
Vivos Therapeutics (VVOS) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Total Non-Current Liabilities for 4 consecutive years, with $25.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $25.0 million; the TTM figure through Mar 2026 stood at $25.0 million (changed N/A YoY), while the FY2025 annual figure was $25.4 million, changed N/A from the prior year.
- Total Non-Current Liabilities slipped to $25.0 million in Q1 2026 per VVOS's latest filing, from $25.4 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $25.4 million in Q4 2025 and bottomed at $8.4 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $16.1 million across 4 years, with a median of $14.9 million in 2023.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 4.38% in 2023 and fell as far as 4.38% in 2023.
- Vivos Therapeutics' Total Non-Current Liabilities stood at $8.4 million in 2022, then increased by 15.14% to $9.7 million in 2023, then soared by 162.66% to $25.4 million in 2025, then decreased by 1.58% to $25.0 million in 2026.
- Business Quant data shows VVOS's Total Non-Current Liabilities at $25.0 million in Q1 2026, $25.4 million in Q4 2025, and $21.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 27.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.00 Mn |
| Dec 31, 2025 | 25.40 Mn |
| Sep 30, 2025 | 21.71 Mn |
| Jun 30, 2025 | 20.10 Mn |
| Sep 30, 2023 | 9.67 Mn |
| Jun 30, 2023 | 9.40 Mn |
| Mar 31, 2023 | 8.77 Mn |
| Mar 31, 2022 | 8.40 Mn |